Tuani, Renalyn C.
HRN: 11-89-84 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2025
CEFUROXIME 500MG (TAB)
11/21/2025
11/27/2025
PO
500mg
BID
SP NSVD
Checking Initial Appropriateness
11/22/2025
CEFUROXIME 1.5GM (VIAL)
11/22/2025
11/24/2025
IV
1.5gm X 3 Doses
Q8hr
UTI
Checking Initial Appropriateness